Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus-Reference-Cited by-同舟云学术

Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus

Published:2021-01-01 Issue:1 Volume:10 Page:810-821
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Yu Danwei¹,Zhu Yuanmei¹^ORCID,Yan Hongxia¹,Wu Tong¹,Chong Huihui¹,He Yuxian¹

Affiliation:

1. NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China

Funder

National Natural Science Foundation of China

CAMS Innovation Fund for Medical Sciences

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2021.1917309

Reference36 articles.

1. The structural biology of type I viral membrane fusion

2. Mechanisms of Viral Membrane Fusion and Its Inhibition

3. Core Structure of gp41 from the HIV Envelope Glycoprotein

4. HIV Entry and Its Inhibition

5. Synthesized Peptide Inhibitors of HIV-1 gp41-dependent Membrane Fusion

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of potent pan‐coronavirus fusion inhibitors with a new design strategy;MedComm;2024-07-28

2. Structural Basis of HIV-1 gp41 N-trimer for Designing Bifunctional Peptide-based Fusion Inhibitors;Current Medicinal Chemistry;2024-04-03

3. Causes and Consequences of Coronavirus Spike Protein Variability;Viruses;2024-01-25

4. Structure and Function of the SARS-CoV-2 6-HB Fusion Core and Peptide-Based Fusion Inhibitors: A Review;Current Medicinal Chemistry;2023-11-24

5. Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides;Antiviral Research;2023-04